Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

97 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Haploinsufficiency of NFKBIA reshapes the epigenome antipodal to the IDH mutation and imparts disease fate in diffuse gliomas.
Bredel M, Espinosa L, Kim H, Scholtens DM, McElroy JP, Rajbhandari R, Meng W, Kollmeyer TM, Malta TM, Quezada MA, Harsh GR, Lobo-Jarne T, Solé L, Merati A, Nagaraja S, Nair S, White JJ, Thudi NK, Fleming JL, Webb A, Natsume A, Ogawa S, Weber RG, Bertran J, Haque SJ, Hentschel B, Miller CR, Furnari FB, Chan TA, Grosu AL, Weller M, Barnholtz-Sloan JS, Monje M, Noushmehr H, Jenkins RB, Rogers CL, MacDonald DR, Pugh SL, Chakravarti A. Bredel M, et al. Among authors: pugh sl. Cell Rep Med. 2023 Jun 20;4(6):101082. doi: 10.1016/j.xcrm.2023.101082. Cell Rep Med. 2023. PMID: 37343523 Free PMC article.
Molecular-Based Recursive Partitioning Analysis Model for Glioblastoma in the Temozolomide Era: A Correlative Analysis Based on NRG Oncology RTOG 0525.
Bell EH, Pugh SL, McElroy JP, Gilbert MR, Mehta M, Klimowicz AC, Magliocco A, Bredel M, Robe P, Grosu AL, Stupp R, Curran W Jr, Becker AP, Salavaggione AL, Barnholtz-Sloan JS, Aldape K, Blumenthal DT, Brown PD, Glass J, Souhami L, Lee RJ, Brachman D, Flickinger J, Won M, Chakravarti A. Bell EH, et al. Among authors: pugh sl. JAMA Oncol. 2017 Jun 1;3(6):784-792. doi: 10.1001/jamaoncol.2016.6020. JAMA Oncol. 2017. PMID: 28097324 Free PMC article. Clinical Trial.
Phase 2 Study of a Temozolomide-Based Chemoradiation Therapy Regimen for High-Risk, Low-Grade Gliomas: Long-Term Results of Radiation Therapy Oncology Group 0424.
Fisher BJ, Pugh SL, Macdonald DR, Chakravatri A, Lesser GJ, Fox S, Rogers CL, Werner-Wasik M, Doyle T, Bahary JP, Fiveash JB, Bovi JA, Howard SP, Michael Yu HH, D'Souza D, Laack NN, Barani IJ, Kwok Y, Wahl DR, Strasser JF, Won M, Mehta MP. Fisher BJ, et al. Among authors: pugh sl. Int J Radiat Oncol Biol Phys. 2020 Jul 15;107(4):720-725. doi: 10.1016/j.ijrobp.2020.03.027. Epub 2020 Apr 3. Int J Radiat Oncol Biol Phys. 2020. PMID: 32251755 Free PMC article. Clinical Trial.
Long-Term Report of a Comprehensive Molecular and Genomic Analysis in NRG Oncology/RTOG 0424: A Phase II Study of Radiation and Temozolomide in High-Risk Grade II Glioma.
Fleming JL, Pugh SL, Fisher BJ, Lesser GJ, Macdonald DR, Bell EH, McElroy JP, Becker AP, Timmers CD, Aldape KD, Rogers CL, Doyle TJ, Werner-Wasik M, Bahary JP, Yu HM, D'Souza DP, Laack NN, Sneed PK, Kwok Y, Won M, Mehta MP, Chakravarti A. Fleming JL, et al. Among authors: pugh sl. JCO Precis Oncol. 2021 Sep 1;5:PO.21.00112. doi: 10.1200/PO.21.00112. eCollection 2021. JCO Precis Oncol. 2021. PMID: 34589661 Free PMC article. Clinical Trial.
Pathology concordance levels for meningioma classification and grading in NRG Oncology RTOG Trial 0539.
Rogers CL, Perry A, Pugh S, Vogelbaum MA, Brachman D, McMillan W, Jenrette J, Barani I, Shrieve D, Sloan A, Bovi J, Kwok Y, Burri SH, Chao ST, Spalding AC, Anscher MS, Bloom B, Mehta M. Rogers CL, et al. Neuro Oncol. 2016 Apr;18(4):565-74. doi: 10.1093/neuonc/nov247. Epub 2015 Oct 22. Neuro Oncol. 2016. PMID: 26493095 Free PMC article. Clinical Trial.
Reply to F. Felix et al and M.F. Fay et al.
Happold C, Gorlia T, Chinot O, Gilbert MR, Nabors LB, Wick W, Pugh SL, Hegi M, Cloughesy T, Roth P, Reardon DA, Perry JR, Mehta MP, Stupp R, Weller M. Happold C, et al. Among authors: pugh sl. J Clin Oncol. 2016 Sep 1;34(25):3107-8. doi: 10.1200/JCO.2016.68.0926. Epub 2016 Jun 13. J Clin Oncol. 2016. PMID: 27298403 Free article. No abstract available.
Independently validated sex-specific nomograms for predicting survival in patients with newly diagnosed glioblastoma: NRG Oncology RTOG 0525 and 0825.
Patil N, Somasundaram E, Waite KA, Lathia JD, Machtay M, Gilbert MR, Connor JR, Rubin JB, Berens ME, Buerki RA, Choi S, Sloan AE, Penas-Prado M, Ashby LS, Blumenthal DT, Werner-Wasik M, Hunter GK, Flickinger JC, Wendland MM, Panet-Raymond V, Robins HI, Pugh SL, Mehta MP, Barnholtz-Sloan JS. Patil N, et al. Among authors: pugh sl. J Neurooncol. 2021 Dec;155(3):363-372. doi: 10.1007/s11060-021-03886-5. Epub 2021 Nov 10. J Neurooncol. 2021. PMID: 34761331 Free PMC article.
Low-risk meningioma: Initial outcomes from NRG Oncology/RTOG 0539.
Rogers CL, Pugh SL, Vogelbaum MA, Perry A, Ashby LS, Modi JM, Alleman AM, Barani IJ, Braunstein S, Bovi JA, de Groot JF, Whitton AC, Lindhorst SM, Deb N, Shrieve DC, Shu HK, Bloom B, Machtay M, Mishra MV, Robinson CG, Won M, Mehta MP. Rogers CL, et al. Among authors: pugh sl. Neuro Oncol. 2023 Jan 5;25(1):137-145. doi: 10.1093/neuonc/noac137. Neuro Oncol. 2023. PMID: 35657335 Free PMC article. Clinical Trial.
Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses.
Chen WC, Choudhury A, Youngblood MW, Polley MC, Lucas CG, Mirchia K, Maas SLN, Suwala AK, Won M, Bayley JC, Harmanci AS, Harmanci AO, Klisch TJ, Nguyen MP, Vasudevan HN, McCortney K, Yu TJ, Bhave V, Lam TC, Pu JK, Li LF, Leung GK, Chan JW, Perlow HK, Palmer JD, Haberler C, Berghoff AS, Preusser M, Nicolaides TP, Mawrin C, Agnihotri S, Resnick A, Rood BR, Chew J, Young JS, Boreta L, Braunstein SE, Schulte J, Butowski N, Santagata S, Spetzler D, Bush NAO, Villanueva-Meyer JE, Chandler JP, Solomon DA, Rogers CL, Pugh SL, Mehta MP, Sneed PK, Berger MS, Horbinski CM, McDermott MW, Perry A, Bi WL, Patel AJ, Sahm F, Magill ST, Raleigh DR. Chen WC, et al. Among authors: pugh sl. Nat Med. 2023 Dec;29(12):3067-3076. doi: 10.1038/s41591-023-02586-z. Epub 2023 Nov 9. Nat Med. 2023. PMID: 37944590 Free PMC article.
RTOG 0518: randomized phase III trial to evaluate zoledronic acid for prevention of osteoporosis and associated fractures in prostate cancer patients.
Kachnic LA, Pugh SL, Tai P, Smith M, Gore E, Shah AB, Martin AG, Kim HE, Nabid A, Lawton CA. Kachnic LA, et al. Among authors: pugh sl. Prostate Cancer Prostatic Dis. 2013 Dec;16(4):382-6. doi: 10.1038/pcan.2013.35. Epub 2013 Oct 1. Prostate Cancer Prostatic Dis. 2013. PMID: 24080992 Free PMC article. Clinical Trial.
97 results